States
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Arthritis Specialists in Mio, MI
LOCAL BUSINESS LISTING(S):
Primary Care Practice Mio, MI - Tel #: (989) 826-3271
Don't see your business? Add a business for free!
Recent Business News for: Arthritis Specialists
Children with chronic illness more likely to develop H1N1 influenza: StudyAs critical care professionals develop a better understanding of the progression of H1N1, they are becoming better prepared to treat children with severe cases, according to a new study that will be published in the March issue of Pediatric Critical Care Medicine (PCCM).
League of Women Voters sponsors important program on Lyme diseaseThe Weston League of Women Voters sponsored an in-depth program on the topic of Lyme disease on March 2. A concerned audience of about 50 people heard three professionals with very different viewpoints about the tick-born disease and its affect on residents of all ages.
Enobia Pharma Taps McGill Expertise In Developing First Effective Treatment For Rare Genetic DisorderDr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth. While osteoporosis later ...
McGill, Enobia Pharma collaborate to develop treatments for serious genetic bone diseasesDr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
McGill, Quebec biotech firm partner for new bone-disease treatment( McGill University ) Dr. Marc McKee of McGill University is collaborating closely with Enobia Pharma Inc., a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Press ReleaseCAMBRIDGE, England, March 5, 2010 /PRNewswire/ -- Napp Pharmaceutical Holdings Limited, based in Cambridge, has risen to position 5 in the Sunday Times Top 100 Best Companies to Work For and remains the highest ranked pharmaceutical company in the UK. This success comes only a few weeks after the company became one of only 50 companies in the UK to be awarded 3 stars by Best Companies through ...